Latest Regulatory Approval News

RPMGlobal shareholders have decisively approved the proposed acquisition by Caterpillar’s subsidiary, marking a pivotal step toward finalising the deal pending regulatory and court approvals.

Imricor Medical Systems has secured Charité University Hospital in Berlin as the second global site for its VISABL-VT clinical trial, marking a significant milestone in real-time MRI-guided cardiac ablation technology.

Bass Oil reported a 2% rise in November oil production alongside a new gas sales agreement with Origin Energy, setting the stage for first gas sales in 2026. Indonesian operations also advanced with production enhancements and upcoming drilling plans.

Sarytogan Graphite Limited updates investors on its $5 million capital raising, highlighting regulatory approval delays but confirming near-term funding to advance its key graphite project.

PYC Therapeutics reports positive safety outcomes from the initial phase of its clinical trial for PYC-003, a promising treatment for Polycystic Kidney Disease. The drug was well tolerated in healthy volunteers, paving the way for patient dosing and further trials.

Peter Warren Automotive Holdings is set to acquire Wakeling Automotive, adding 16 brands and 30 dealerships to its portfolio and boosting its presence in the fast-growing Western Sydney market.

RPMGlobal shareholders convened on 19 December 2025 to vote on Caterpillar's $5.00 per share acquisition proposal, with strong board support and regulatory hurdles nearing resolution.

South Harz Potash Limited has lodged three exploration permit applications for the Torsby West Project in Sweden, securing a 25km corridor rich in copper-gold-cobalt mineralisation. This move complements their existing Glava assets and positions the company strongly in a highly prospective Scandinavian IOCG district.

GBM Resources has partially completed its $8 million placement to Wise Walkers but faces delays in receiving the remaining funds due to Chinese foreign exchange controls. Shareholder approval for the balance is now pending.

Legacy Iron Ore has ceased mining operations at Mt Celia, marking the end of Phase I, while advancing heap leach studies and exploring a Carbon-in-Leach plant to drive future growth.

Avecho Biotechnology is close to completing recruitment for the interim analysis cohort of its pivotal Phase III trial testing a CBD capsule for insomnia, with results expected in the first half of 2026.

Mount Ridley Mines has locked in nearly $1.8 million through a fully underwritten exercise of expiring unlisted options, ensuring financial backing for its Mount Ridley Project exploration and metallurgical programs.